The government is pushing to reform the drug pricing system to reduce the number of generics. It is said that the authorities are considering a plan that does not grant the premium price allowed for innovative pharmaceuticals to generics that exceed a certain number.

The analysis is that the government's decision to regulate the number of generics was influenced by the large amount of Forxiga generics that entered the market at once in April. 57 generic drugs were released as soon as the patent term for Forxiga expired.

However, this was possible because the generic drugs were approved before the consigned bioequivalence test restriction system was implemented.

The amendme